Haisco Pharmaceutical Group Co., Ltd. (002653.SZ)
CNY 42.8
(-0.23%)
CNY 42.8
(-0.23%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.81 Billion CNY | -13.45% |
| 2022 | 2.1 Billion CNY | 68.31% |
| 2021 | 1.24 Billion CNY | 13.07% |
| 2020 | 1.1 Billion CNY | 2.31% |
| 2019 | 1.08 Billion CNY | 15.51% |
| 2018 | 935 Million CNY | 16.87% |
| 2017 | 800.05 Million CNY | -2.82% |
| 2016 | 823.29 Million CNY | 30.17% |
| 2015 | 632.46 Million CNY | 58.12% |
| 2014 | 400 Million CNY | 74.15% |
| 2013 | 229.68 Million CNY | 355.11% |
| 2012 | 50.46 Million CNY | 4381.57% |
| 2011 | 1.12 Million CNY | -94.8% |
| 2010 | 21.67 Million CNY | 18.05% |
| 2009 | 18.36 Million CNY | -30.19% |
| 2008 | 26.3 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 1.4 Billion CNY | -22.08% |
| 2024 Q1 | 2.03 Billion CNY | 11.93% |
| 2024 Q2 | 1.8 Billion CNY | -11.3% |
| 2023 Q1 | 1.82 Billion CNY | -13.31% |
| 2023 FY | 1.81 Billion CNY | -13.45% |
| 2023 Q4 | 1.81 Billion CNY | 14.89% |
| 2023 Q3 | 1.58 Billion CNY | -14.54% |
| 2023 Q2 | 1.85 Billion CNY | 1.69% |
| 2022 FY | 2.1 Billion CNY | 68.31% |
| 2022 Q4 | 2.1 Billion CNY | 3.41% |
| 2022 Q3 | 2.03 Billion CNY | -0.22% |
| 2022 Q2 | 2.03 Billion CNY | 28.96% |
| 2022 Q1 | 1.58 Billion CNY | 26.49% |
| 2021 Q3 | 1.33 Billion CNY | -1.08% |
| 2021 Q2 | 1.34 Billion CNY | 21.54% |
| 2021 FY | 1.24 Billion CNY | 13.07% |
| 2021 Q1 | 1.11 Billion CNY | 0.51% |
| 2021 Q4 | 1.24 Billion CNY | -6.43% |
| 2020 Q1 | 1.37 Billion CNY | 27.31% |
| 2020 Q2 | 1.5 Billion CNY | 9.82% |
| 2020 Q3 | 1.43 Billion CNY | -4.97% |
| 2020 Q4 | 1.1 Billion CNY | -23.0% |
| 2020 FY | 1.1 Billion CNY | 2.31% |
| 2019 Q1 | 1.03 Billion CNY | 10.16% |
| 2019 Q3 | 1.04 Billion CNY | 1.96% |
| 2019 Q4 | 1.08 Billion CNY | 3.85% |
| 2019 FY | 1.08 Billion CNY | 15.51% |
| 2019 Q2 | 1.02 Billion CNY | -0.97% |
| 2018 FY | 935 Million CNY | 16.87% |
| 2018 Q1 | 898.29 Million CNY | 12.28% |
| 2018 Q2 | 729.77 Million CNY | -18.76% |
| 2018 Q3 | 395 Million CNY | -45.87% |
| 2018 Q4 | 935 Million CNY | 136.71% |
| 2017 Q4 | 800.05 Million CNY | -1.29% |
| 2017 FY | 800.05 Million CNY | -2.82% |
| 2017 Q3 | 810.52 Million CNY | 13.86% |
| 2017 Q2 | 711.83 Million CNY | -13.45% |
| 2017 Q1 | 822.42 Million CNY | -0.11% |
| 2016 Q2 | 832.49 Million CNY | 56.58% |
| 2016 FY | 823.29 Million CNY | 30.17% |
| 2016 Q1 | 531.65 Million CNY | -15.94% |
| 2016 Q4 | 823.29 Million CNY | -1.05% |
| 2016 Q3 | 832.05 Million CNY | -0.05% |
| 2015 Q2 | 400 Million CNY | 0.0% |
| 2015 FY | 632.46 Million CNY | 58.12% |
| 2015 Q4 | 632.46 Million CNY | 46.47% |
| 2015 Q3 | 431.8 Million CNY | 7.95% |
| 2015 Q1 | 400 Million CNY | 0.0% |
| 2014 FY | 400 Million CNY | 74.15% |
| 2014 Q3 | 400 Million CNY | 33.33% |
| 2014 Q2 | 300 Million CNY | 200.0% |
| 2014 Q1 | 100 Million CNY | -56.46% |
| 2014 Q4 | 400 Million CNY | 0.0% |
| 2013 Q3 | 230 Million CNY | 141.82% |
| 2013 FY | 229.68 Million CNY | 355.11% |
| 2013 Q4 | 229.68 Million CNY | -0.14% |
| 2013 Q1 | 292.86 Thousand CNY | -99.42% |
| 2013 Q2 | 95.11 Million CNY | 32375.96% |
| 2012 Q2 | 806.76 Thousand CNY | -16.71% |
| 2012 Q3 | 50.64 Million CNY | 6176.97% |
| 2012 Q4 | 50.46 Million CNY | -0.34% |
| 2012 FY | 50.46 Million CNY | 4381.57% |
| 2012 Q1 | 968.67 Thousand CNY | -13.98% |
| 2011 FY | 1.12 Million CNY | -94.8% |
| 2011 Q2 | 21.43 Million CNY | 0.0% |
| 2011 Q3 | 1.28 Million CNY | -94.01% |
| 2011 Q4 | 1.12 Million CNY | -12.33% |
| 2010 FY | 21.67 Million CNY | 18.05% |
| 2010 Q4 | 21.67 Million CNY | 0.0% |
| 2009 FY | 18.36 Million CNY | -30.19% |
| 2008 FY | 26.3 Million CNY | 0.0% |